Recursion Pharmaceuticals Inc (RXRX)
5.70
-0.05
(-0.87%)
USD |
NASDAQ |
Nov 22, 16:00
5.75
+0.05
(+0.88%)
After-Hours: 20:00
Recursion Pharmaceuticals Price: 5.70 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 22, 2024 | 5.78 | 5.99 | 5.60 | 5.70 | 13.61M |
| Nov 21, 2024 | 6.02 | 6.03 | 5.62 | 5.75 | 12.35M |
| Nov 20, 2024 | 6.30 | 6.37 | 5.70 | 6.04 | 17.00M |
| Nov 19, 2024 | 6.01 | 6.33 | 5.84 | 6.27 | 9.339M |
| Nov 18, 2024 | 6.25 | 6.26 | 5.90 | 6.10 | 10.41M |
| Nov 15, 2024 | 6.89 | 6.92 | 6.15 | 6.175 | 10.54M |
| Nov 14, 2024 | 7.39 | 7.58 | 6.88 | 6.91 | 6.589M |
| Nov 13, 2024 | 7.795 | 8.040 | 7.31 | 7.32 | 6.591M |
| Nov 12, 2024 | 7.52 | 8.045 | 7.43 | 7.58 | 6.811M |
| Nov 11, 2024 | 7.50 | 8.49 | 7.23 | 7.84 | 15.58M |
| Nov 08, 2024 | 6.86 | 7.205 | 6.81 | 7.10 | 6.667M |
| Nov 07, 2024 | 6.92 | 7.09 | 6.68 | 6.93 | 5.800M |
| Nov 06, 2024 | 6.95 | 7.05 | 6.77 | 6.97 | 7.362M |
| Nov 05, 2024 | 6.59 | 6.83 | 6.465 | 6.82 | 4.354M |
| Nov 04, 2024 | 6.40 | 6.69 | 6.22 | 6.64 | 3.885M |
| Nov 01, 2024 | 6.36 | 6.58 | 6.335 | 6.40 | 3.630M |
| Oct 31, 2024 | 6.65 | 6.685 | 6.32 | 6.32 | 4.378M |
| Oct 30, 2024 | 6.62 | 6.90 | 6.60 | 6.68 | 4.475M |
| Oct 29, 2024 | 6.85 | 6.85 | 6.65 | 6.74 | 2.507M |
| Oct 28, 2024 | 6.58 | 6.945 | 6.56 | 6.87 | 4.547M |
| Oct 25, 2024 | 6.42 | 6.61 | 6.28 | 6.48 | 3.518M |
| Oct 24, 2024 | 6.45 | 6.45 | 6.195 | 6.36 | 2.934M |
| Oct 23, 2024 | 6.55 | 6.63 | 6.24 | 6.33 | 3.977M |
| Oct 22, 2024 | 6.70 | 6.79 | 6.56 | 6.61 | 2.844M |
| Oct 21, 2024 | 6.935 | 6.94 | 6.590 | 6.76 | 3.966M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.56
Minimum
May 02 2023
41.33
Maximum
Jul 13 2021
11.96
Average
8.96
Median
Jul 08 2022
Price Benchmarks
| Revance Therapeutics Inc | 3.73 |
| NovaBay Pharmaceuticals Inc | 0.681 |
| Palatin Technologies Inc | 0.96 |
| iBio Inc | 2.64 |
| Theriva Biologics Inc | 1.28 |
Price Related Metrics
| PS Ratio | 21.68 |
| PEG Ratio | -0.5966 |
| Price to Book Value | 3.115 |
| Earnings Yield | -27.19% |
| Market Cap | 1.634B |
| PEGY Ratio | -0.5966 |